Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-14

Clinical Trial Update: Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin [Phase 3]

View source ↗

Summary

Phase 3 trial results of voclosporin for lupus nephritis completed; assesses renal response in lupus nephritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Voclosporin (voclosporin)

Snippet

Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Lupus Nephritis | Phase 3 | Status: COMPLETED | Results posted: 2022-12-14